Latest Breaking News On - Psilocybin for neuropsychiatric disorders - Page 1 : comparemela.com

Tryp Therapeutics Announces Publication of International PCT Patent Application for the Intravenous Administration of Psilocin and Psilocybin

Tryp Therapeutics Announces Publication of International PCT Patent Application for the Intravenous Administration of Psilocin and Psilocybin
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaRobin carhart harrisInformationjohn nesbett jennifer belodeauJim gilliganTryp therapeutics incUniversity of floridaUniversity of michiganWorld intellectual property organizationWill host investor update tuesdayMethods for the useTryp therapeuticsChief executive officerTryp therapeuticTryp therapeuticstryp therapeutics

Tryp Therapeutics Announces Publication of International

Enables Potentially Scalable Model For The Broad Roll-Out of Psychedelic Treatments Company Will Host Investor Update Tuesday, October 4th .

United kingdomUnited statesBritish columbiaJohn nesbett jennifer belodeauRobin carhart harrisJim gilliganTryp therapeutics incUniversity of floridaUniversity of michiganWorld intellectual property organizationWill host investor update tuesdayMethods for the useTryp therapeuticsChief executive officerTryp therapeuticPsilocybin for neuropsychiatric disorders

PsychedelicNewsBreaks – Tryp Therapeutics Inc (CSE: TRYP) (OTCQB: TRYPF) Announces Methodical Expansion of Its IP Portfolio

PsychedelicNewsBreaks – Tryp Therapeutics Inc (CSE: TRYP) (OTCQB: TRYPF) Announces Methodical Expansion of Its IP Portfolio
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJim gilliganTryp therapeutics incUniversity of floridaUniversity of michiganTryp therapeuticsPsilocybin for neuropsychiatric disordersPhones only

Tryp Therapeutics Appoints Jim O Neill as Chief Financial Officer

KELOWNA, British Columbia, Sept. 19, 2022 Tryp Therapeutics Inc. , a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical needs,. | September 19, 2022

United kingdomUnited statesBritish columbiaJim oneillJim gilliganSid taubenfeldWilfrid laurier universityTryp therapeutics incUniversity of floridaOneill services corpInstitutional marketing servicesGlobenewswire incUniversity of michiganJimo neillChief financialChief financial officer

Tryp Therapeutics Retains IMS Investor Relations

Tryp Therapeutics Retains IMS Investor Relations
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaJohn nesbettInformationjohn nesbett jennifer belodeauJim gilliganTryp therapeutics incUniversity of floridaInstitutional marketing servicesUniversity of michiganChief executive officerTryp therapeuticsWall streetTryp therapeuticstryp therapeuticsPsilocybin for neuropsychiatric disordersNew canaan